Why the study?
Indications for TAVI have gradually expanded, prompting an analysis of temporal trends in TAVI characteristics over 10 years at a high-volume academic center.
Do patient characteristics, procedural complications, and 1-year mortality of TAVI change over a 10-year period in a high-volume academic center?
Cohort (n=506)
No
Do patient characteristics, procedural complications, and 1-year mortality of TAVI change over a 10-year period in a high-volume academic center?
Hazard Ratio: 2.3 (95% CI 1.27–4.16)
Absolute Event Rate: 9.1% vs 20%
p-value: p=0.004
BACKGROUND: Indications for transcatheter aortic valve implantation (TAVI) have gradually expanded since its introduction. AIMS: The aim was to analyze temporal trends in TAVI characteristics based on the experience of a high-volume academic center over the period of 10 years. METHODS: Five hundred and six consecutive (n = 506) patients with 1-year follow-up were divided into early (G1, years 2010-2013, n = 130), intermediate (G2, 2014-2016, n = 164) and recent (G3, 2017-2019, n = 212) experience groups. RESULTS: Patient's age remained constant over time (mean [SD]; G1 = 79.1 [7.1] years vs G2 = 79.1 [7.1] years vs G3 = 79.7 [6.6] years, P = 0.73) but surgical risk in G3 was lower (log Euroscore, median [IQR]: G1 = 14.0 [8.4-20.2] vs G2 = 12.0 [7.0-22.2] vs G3 = 5.1 [3.5-8.5]; P <0.001). Major/life-threatening bleeding (G1 = 26.9% vs G2 = 12.8% vs G3 = 9.4%; P <0.001), major vascular complications (G1 = 15.4% vs G2 = 8.5% vs G3 = 5.7%; P = 0.02) and moderate/severe paravalvular leak (G1 = 16.2% vs G2 = 11% vs G3 = 7.5%; P = 0.046) were decreasing with time. There was a significant drop in all-cause 1-year mortality in G3 (G1 = 20% vs G2 = 17.7% vs G3 = 9.1%; log rank = 0.01). CONCLUSIONS: The age of TAVI recipients remained unchanged over the last decade. Decreasing surgical risk coupled with improvements in procedural technique and care resulted in fewer periprocedural complications and better 1-year survival.
No takes yet. Share an insight, caveat, or question.
Huczek et al. (2021) conducted a cohort in Severe symptomatic aortic stenosis (n=506). Recent TAVI experience (2017-2019) vs. Early TAVI experience (2010-2013) was evaluated on 1-year all-cause mortality (HR 2.30, 95% CI 1.27-4.16, p=0.004).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: